Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?
Biopharmaceutical company Biocon’s shares fell 6% to Rs 320.80 in Thursday trade on the BSE after the firm reported a second-quarter loss, impacted by a deferred tax charge. The drugmaker’s net profit plunged 84.2% year-on-year (YoY) in Q2 to Rs 27.1 crore, sharply down from Rs 172 crore reported in the same quarter of the…
READ MORE
Federal Bank shares in focus post Q2 results. Should you buy, sell, or hold?
Private sector lender Federal Bank shares will be in focus on Tuesday after the bank posted an 11% increase in net profit to Rs 1,057 crore in the September quarter. The lender had earned a net profit of Rs 954 crore in the year-ago period. Federal Bank said in a regulatory filing that its total…
READ MORE